Drug Delivery Systems Using Surface Markers for Targeting Cancer Stem Cells

James T Oswald1, Haritosh Patel1, Daid Khan1

  • 1School Of Nanotechnology Engineering, University of Waterloo, Waterloo, ON N2L 3G1, Canada.

Summary

Cancer stem cells (CSCs) resist traditional therapies due to unique traits. Nanomedicine offers new ways to target CSC surface markers, potentially overcoming chemoresistance and preventing cancer relapse.